Alimera Sciences News

Alliance Global Partners Downgrades Alimera Sciences to Neutral From Buy, Adjusts Price Target to $5.50 From $8

MT NewswiresJun 25 12:03 ET

Alimera Sciences Analyst Ratings

BenzingaJun 25 07:04 ET

Alimera Sciences Analyst Ratings

BenzingaMay 16 07:11 ET

Robust Growth and Promising Trials: Buy Rating for Alimera Sciences

TipRanksMay 16 06:45 ET

Alimera Sciences Analyst Ratings

BenzingaMar 25 08:06 ET

Alimera Sciences Analyst Ratings

BenzingaMar 8 13:02 ET

Buy Rating Affirmed for Alimera Sciences Amid Strong Financial Performance and Promising Clinical Trials

TipRanksMar 8 12:30 ET

The Latest Analyst Ratings for Alimera Sciences

BenzingaAug 14, 2023 15:00 ET

HC Wainwright & Co. Reiterates Buy on Alimera Sciences, Maintains $5 Price Target

BenzingaAug 14, 2023 06:39 ET

Alimera Sciences Analyst Ratings

BenzingaAug 14, 2023 06:38 ET

Alliance Global Partners Upgrades Alimera Sciences to Buy, Raises Price Target to $8

BenzingaJun 12, 2023 08:18 ET

HC Wainwright & Co. Reiterates Buy on Alimera Sciences, Maintains $5 Price Target

BenzingaMay 25, 2023 09:37 ET

HC Wainwright Adjusts Price Target on Alimera Sciences to $5 From $9, Keeps Buy Rating

MT NewswiresMay 19, 2023 09:51 ET

HC Wainwright & Co. Maintains Buy on Alimera Sciences, Lowers Price Target to $5

BenzingaMay 19, 2023 06:20 ET

HC Wainwright & Co. Reiterates Buy on Alimera Sciences, Maintains $9 Price Target

BenzingaApr 3, 2023 06:22 ET

Alimera Sciences Analyst Ratings

BenzingaFeb 23, 2023 06:49 ET

HC Wainwright & Co. Reiterates Buy on Alimera Sciences, Maintains $9 Price Target

BenzingaFeb 23, 2023 06:18 ET

Alimera Sciences Analyst Ratings

Benzinga Analyst RatingsNov 21, 2022 08:32 ET

Alliance Global Partners Downgrades Alimera Sciences to Neutral, Lowers Price Target to $4.5

Benzinga Real-time NewsNov 21, 2022 08:32 ET

HC Wainwright Adjusts Price Target on Alimera Sciences to $9 From $8, Reiterates Buy Rating

MT NewswiresJul 28, 2022 09:11 ET